Amarin Corp Plc (AMRN)

[Whalatane]

Another study VALIDATING the Reduce -It trial changes everything .
The Cardiologists I know want independent confirmation that high dose EPA lowers CV event risk

Statins had numerous trials confirming risk reduction… look it up

Dr Taub will present the RESPECT EPA trial . This is no
small thing
Dr Taub is a rising star .. especially for conference presentations .
I doubt if she would agree to present unless she felt it was a well run trial that would influence prescribing activities.

So it’s IMHO a big deal for AMRN

Hopefully RESPECT shows at least a stat sig risk reduction of at least 15 %

IF the RR is 15 % will a p value of say .01 … then that would imply a higher RR in a US R-IT profile population on 4 gms of Vascepa ( bigger jump in serum EPA levels )

15 % RR in RESPECT EPA is in my mind a 20% plus RR in a similar secondarily prevention US population

So we need RESPECT EPA to succeed

Kiwi